The XpresSpa Group said this week it has expanded its XpresCheck testing services beyond COVID-19, as XpresCheck locations now offer rapid testing services for other communicable diseases, including influenza, mononucleosis and group A streptococcus.
XpresCheck’s current locations at John Kennedy International (JFK) and Newark Liberty International (EWR) airports will also now provide this season’s 2020/21 flu vaccination, as well as a quadrivalent high-dose flu vaccine recommended for seniors.
“This pandemic is prompting people to change the way they think about their health when traveling, paving the way for this new industry segment in a post-COVID-19 world,” said Doug Satzman, XpresSpa CEO. “XpresCheck is capitalizing on its existing infrastructure to provide essential services at airports by leveraging our resources to help in the fight against COVID-19, and by becoming the first airport coronavirus testing company. The simple administration of flu vaccinations paves the way for future COVID-19 vaccinations when they are approved and readily available in the market.”
XpresCheck continues to provide several COVID-19 testing options include a rapid molecular COVID-19 test, the Polymerase Chain Reaction (PCR) Test, and the Blood Antibody Test.
These services are available to all airport employees, including airline employees, contractors TSA officers, and U.S. Customs and Border Protection (CPB) agents, as well as airline passengers. All insurance plans are accepted outside of network and all patient information remains private and HIPAA-compliant.
